DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Panitumumab is an investigational drug.
There have been 207 clinical trials for Panitumumab. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2013.
The most common disease conditions in clinical trials are Colorectal Neoplasms, Adenocarcinoma, and Carcinoma, Squamous Cell. The leading clinical trial sponsors are Amgen, National Cancer Institute (NCI), and Takeda.
There are two hundred and sixty-six US patents protecting this investigational drug and three international patents.
Recent Clinical Trials for Panitumumab
|Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures||Stanford University||Phase 1/Phase 2|
|Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer||Tesaro, Inc.||Phase 2|
|Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer||Emory University||Phase 2|
Top disease conditions for Panitumumab
Top clinical trial sponsors for Panitumumab
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Panitumumab||Start Trial||Trilayer coated pharmaceutical packaging||SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)||Start Trial|
|Panitumumab||Start Trial||Methods of enhancing antibody-dependent cellular cytotoxicity||VentiRx Pharmaceuticals, Inc. (Seattle, WA)||Start Trial|
|Panitumumab||Start Trial||Encapsulated agents and methods of making and using thereof||University of Georgia Research Foundation, Inc. (Athens, GA)||Start Trial|
|Panitumumab||Start Trial||High resolution melting analysis as a prescreening tool||Roche Molecular Systems, Inc. (Pleasanton, CA)||Start Trial|
|Panitumumab||Start Trial||K-ras mutations and anti-EGFr antibody therapy||AMGEN, INC (Thousand Oaks, CA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|